Yumi Takiyama

3PUBLICATIONS
0CO-AUTHORS
MechanobiologyReaction engineering (excl. nuclear reactions)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 20, 2025
Role of metallothionein 3 in diabetic nephropathy via interplay with HIF-1α.

Yuri Takiyama, Yumi Takiyama, Takao Takiyama

|Jan 24, 2024
A natural Nrf2 activator glucoraphanin improves hepatic steatosis in high-fat diet-induced obese male mice associated with AMPK activation.

Suratsawadee Promsuwan, Kazuki Sawamoto, Liang Xu

|Oct 16, 2019
Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy.

Ryoichi Bessho, Yumi Takiyama, Takao Takiyama

Pageof 1

Frequent Collaborators